ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,199, issued on June 24, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).
"Stable antibody formulation" was invented by Yuan Cao (White Plains, N.Y.), Dingjiang Liu (Pleasantville, N.Y.) and Long Xu (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides stable pharmaceutical formulations comprising a human antibody that specifically binds to Ebola Virus (EBOV). In certain embodiments, the formulations contain, in addition to an anti-EBOV antibody, a buffer, an amino acid, a non-ionic surfactant, and a stabilizer. The pharmaceutical formulations of the present disclosure exhibit a substantial degree o...